LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 5 of total 5

Search options

  1. Article ; Online: Immunotherapy using purified protein derivative in the treatment of warts: An open uncontrolled trial.

    Saoji, Vikrant / Lade, Nitin R / Gadegone, Rutuja / Bhat, Arun

    Indian journal of dermatology, venereology and leprology

    2016  Volume 82, Issue 1, Page(s) 42–46

    Abstract: Background: Warts are known to clear spontaneously with the development of cell-mediated immunity (CMI) to the virus. Purified protein derivative (PPD) of tuberculin bacilli has been used as a non-specific stimulant of CMI to achieve this outcome.: ... ...

    Abstract Background: Warts are known to clear spontaneously with the development of cell-mediated immunity (CMI) to the virus. Purified protein derivative (PPD) of tuberculin bacilli has been used as a non-specific stimulant of CMI to achieve this outcome.
    Aim: To study the effect of PPD in the treatment of warts.
    Methods: Patients with difficult-to-treat warts were selected for immunotherapy. Each patient received 2.5 TU of PPD intralesionally in a few warts. A total of four sessions were given at 2 weekly intervals and patients were followed up for 6 months after the last dose.
    Results: Sixty-one patients were recruited of which 55 completed 6 months follow up and were available for analysis. Of these, 25 had verruca vulgaris, 18 had verruca plana and 12 had plantar warts. Forty two (76%) patients showed complete clearance after four sessions while the remaining 13 (24%) patients were non-responders. One patient developed a recurrence after total clearance during the follow-up period. Adverse effects were erythema, edema and pain at the site of injections.
    Limitations: As this was an uncontrolled trial, there is no comparison with a non-intervention group. Also, a Mantoux test was not done due to practical difficulties.
    Conclusion: Immunotherapy with PPD is helpful in the treatment of cutaneous warts.
    MeSH term(s) Adolescent ; Adult ; Child ; Child, Preschool ; Female ; Follow-Up Studies ; Humans ; Immunotherapy/methods ; Injections, Intralesional ; Male ; Middle Aged ; Prospective Studies ; Skin Neoplasms/pathology ; Skin Neoplasms/physiopathology ; Skin Neoplasms/therapy ; Treatment Outcome ; Tuberculin/administration & dosage ; Warts/pathology ; Warts/physiopathology ; Warts/therapy ; Young Adult
    Chemical Substances Tuberculin
    Language English
    Publishing date 2016-01
    Publishing country India
    Document type Clinical Trial ; Journal Article
    ZDB-ID 416068-x
    ISSN 0973-3922 ; 0019-5162 ; 0378-6323
    ISSN (online) 0973-3922
    ISSN 0019-5162 ; 0378-6323
    DOI 10.4103/0378-6323.171650
    Database MEDical Literature Analysis and Retrieval System OnLINE

    Full text online

    More links

    Kategorien

    In stock of ZB MED Cologne/Königswinter

    Zs.A 85: Show issues Location:
    Je nach Verfügbarkeit (siehe Angabe bei Bestand)
    bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
    Jg. 1995 - 2021: Lesesall (1.OG)
    ab Jg. 2022: Lesesaal (EG)

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  2. Article ; Online: Off-the-shelf Vδ1 gamma delta T cells engineered with glypican-3 (GPC-3)-specific chimeric antigen receptor (CAR) and soluble IL-15 display robust antitumor efficacy against hepatocellular carcinoma.

    Makkouk, Amani / Yang, Xue Cher / Barca, Taylor / Lucas, Anthony / Turkoz, Mustafa / Wong, Jonathan T S / Nishimoto, Kevin P / Brodey, Mary M / Tabrizizad, Maryam / Gundurao, Smitha R Y / Bai, Lu / Bhat, Arun / An, Zili / Abbot, Stewart / Satpayev, Daulet / Aftab, Blake T / Herrman, Marissa

    Journal for immunotherapy of cancer

    2021  Volume 9, Issue 12

    Abstract: Background: Glypican-3 (GPC-3) is an oncofetal protein that is highly expressed in various solid tumors, but rarely expressed in healthy adult tissues and represents a rational target of particular relevance in hepatocellular carcinoma (HCC). Autologous ...

    Abstract Background: Glypican-3 (GPC-3) is an oncofetal protein that is highly expressed in various solid tumors, but rarely expressed in healthy adult tissues and represents a rational target of particular relevance in hepatocellular carcinoma (HCC). Autologous chimeric antigen receptor (CAR) αβ T cell therapies have established significant clinical benefit in hematologic malignancies, although efficacy in solid tumors has been limited due to several challenges including T cell homing, target antigen heterogeneity, and immunosuppressive tumor microenvironments. Gamma delta (γδ) T cells are highly cytolytic effectors that can recognize and kill tumor cells through major histocompatibility complex (MHC)-independent antigens upregulated under stress. The Vδ1 subset is preferentially localized in peripheral tissue and engineering with CARs to further enhance intrinsic antitumor activity represents an attractive approach to overcome challenges for conventional T cell therapies in solid tumors. Allogeneic Vδ1 CAR T cell therapy may also overcome other hurdles faced by allogeneic αβ T cell therapy, including graft-versus-host disease (GvHD).
    Methods: We developed the first example of allogeneic CAR Vδ1 T cells that have been expanded from peripheral blood mononuclear cells (PBMCs) and genetically modified to express a 4-1BB/CD3z CAR against GPC-3. The CAR construct (GPC-3.CAR/secreted interleukin-15 (sIL)-15) additionally encodes a constitutively-secreted form of IL-15, which we hypothesized could sustain proliferation and antitumor activity of intratumoral Vδ1 T cells expressing GPC-3.CAR.
    Results: GPC-3.CAR/sIL-15 Vδ1 T cells expanded from PBMCs on average 20,000-fold and routinely reached >80% purity. Expanded Vδ1 T cells showed a primarily naïve-like memory phenotype with limited exhaustion marker expression and displayed robust in vitro proliferation, cytokine production, and cytotoxic activity against HCC cell lines expressing low (PLC/PRF/5) and high (HepG2) GPC-3 levels. In a subcutaneous HepG2 mouse model in immunodeficient NSG mice, GPC-3.CAR/sIL-15 Vδ1 T cells primarily accumulated and proliferated in the tumor, and a single dose efficiently controlled tumor growth without evidence of xenogeneic GvHD. Importantly, compared with GPC-3.CAR Vδ1 T cells lacking sIL-15, GPC-3.CAR/sIL-15 Vδ1 T cells displayed greater proliferation and resulted in enhanced therapeutic activity.
    Conclusions: Expanded Vδ1 T cells engineered with a GPC-3 CAR and sIL-15 represent a promising platform warranting further clinical evaluation as an off-the-shelf treatment of HCC and potentially other GPC-3-expressing solid tumors.
    MeSH term(s) Animals ; Apoptosis ; Carcinoma, Hepatocellular/genetics ; Carcinoma, Hepatocellular/immunology ; Carcinoma, Hepatocellular/pathology ; Carcinoma, Hepatocellular/therapy ; Cell Proliferation ; Female ; Glypicans/immunology ; Humans ; Immunotherapy, Adoptive/methods ; Interleukin-15/immunology ; Leukocytes, Mononuclear ; Liver Neoplasms/genetics ; Liver Neoplasms/immunology ; Liver Neoplasms/pathology ; Liver Neoplasms/therapy ; Mice ; Mice, Inbred NOD ; Mice, SCID ; Receptors, Antigen, T-Cell, gamma-delta/immunology ; Receptors, Chimeric Antigen/immunology ; Tumor Cells, Cultured ; Xenograft Model Antitumor Assays
    Chemical Substances GPC3 protein, human ; Glypicans ; IL15 protein, human ; Interleukin-15 ; Receptors, Antigen, T-Cell, gamma-delta ; Receptors, Chimeric Antigen
    Language English
    Publishing date 2021-12-16
    Publishing country England
    Document type Journal Article
    ZDB-ID 2719863-7
    ISSN 2051-1426 ; 2051-1426
    ISSN (online) 2051-1426
    ISSN 2051-1426
    DOI 10.1136/jitc-2021-003441
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  3. Article ; Online: Binding Rate Screen - a high-throughput assay in soluble lysate for prioritizing protein expression constructs.

    Tian-Yu, Jiamin / Licht, Stuart / Pardee, Gwynn / Bhat, Arun / Cao, Ying / Gao, Wei / Sangalang, Emma / Zaror, Isabel

    Analytical biochemistry

    2010  Volume 399, Issue 2, Page(s) 276–283

    Abstract: Identification of constructs suitable for the recombinant protein production pipeline is a bottleneck for structural genomics efforts, as most methods require purified proteins and/or are labor-intensive. Here, we present a novel high-throughput approach, ...

    Abstract Identification of constructs suitable for the recombinant protein production pipeline is a bottleneck for structural genomics efforts, as most methods require purified proteins and/or are labor-intensive. Here, we present a novel high-throughput approach, Binding Rate Screen, that can alleviate this bottleneck by screening expression constructs in crude soluble lysate. This functional screen utilizes the frequently employed hexahistidine (His(6)) tag as a reporter, and measures its binding rate to an affinity matrix as a metric to reflect aggregation, concentration, and purifiability of the target protein. The constructs with the highest binding rates also exhibit high expression of soluble monomeric protein as judged by analytical size-exclusion chromatography. Constructs expressing variations of the target protein can be prioritized on a time scale of minutes, which is at least 10-100 times faster than any other technologies currently available.
    MeSH term(s) High-Throughput Screening Assays/methods ; Histidine/genetics ; Histidine/metabolism ; Immunoassay ; Interferometry ; Light ; Luminescent Measurements ; Oligopeptides/genetics ; Oligopeptides/metabolism ; Protein Binding ; Recombinant Fusion Proteins/genetics ; Recombinant Fusion Proteins/metabolism
    Chemical Substances His-His-His-His-His-His ; Oligopeptides ; Recombinant Fusion Proteins ; Histidine (4QD397987E)
    Language English
    Publishing date 2010-04-15
    Publishing country United States
    Document type Journal Article
    ZDB-ID 1110-1
    ISSN 1096-0309 ; 0003-2697
    ISSN (online) 1096-0309
    ISSN 0003-2697
    DOI 10.1016/j.ab.2009.11.012
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

    In stock of ZB MED Cologne/Königswinter

    Zs.A 389: Show issues Location:
    Je nach Verfügbarkeit (siehe Angabe bei Bestand)
    bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
    Jg. 1995 - 2021: Lesesall (1.OG)
    ab Jg. 2022: Lesesaal (EG)

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  4. Article ; Online: Effect of Graded Head-Up Tilt & Head-Reverse Tilt on the Sympathetic Nervous System Versus Parasympathetic Nervous System

    Sabita Yograj, A.K. Sadhu, Leela Kalsotra, Anjali N. Bhat, Arun Arora

    JK Science : Journal of Medical Education & Research, Vol 6, Iss 3, Pp 144-

    2004  Volume 148

    Abstract: The study was undertaken on 150 healthy human subjects of both the sexes in the age group of 18-38 years to assess the effect of graded head-up tilt (HUT) and head-reverse tilt (HRT) on sympatheticnervous system Vs parasympathetic nervous system. The ... ...

    Abstract The study was undertaken on 150 healthy human subjects of both the sexes in the age group of 18-38 years to assess the effect of graded head-up tilt (HUT) and head-reverse tilt (HRT) on sympatheticnervous system Vs parasympathetic nervous system. The tilt positions used were 00, 300, 600, 300Rand 00R. The parameters and test performed were pulse rate, blood pressure, cold pressor test, QTCinterval, valsalva ratio and expiratory-inspiratory (E:I) ratio. On graded head-up tilt (600) pulse rateand diastolic blood pressure showed significant increase. Cold pressor test and QTc interval showedsignificant increase from 300 to 600 tilt. The valsalva and E:I ratios did not show any significantchange on graded HUT. On reversal of tilt all the parameters showing significant increase returnedto near pre-tilt values. These responses clearly indicate that graded HUT leads to decrease inparasympathetic reactivity but increase in sympathetic reactivity, which is more significant duringhigher tilt levels (300 to 600). On reversal of tilt both the parasympathetic reactivity and the sympatheticreactivity i.e. autonomic reactivity return to normal pre-tilt level.
    Keywords Head-up tilt ; Head-reverse tilt ; Autonomic reactivity ; Parasympathetic & Sympathetic reactivity ; Medicine (General) ; R5-920 ; Medicine ; R ; DOAJ:Medicine (General) ; DOAJ:Health Sciences
    Language English
    Publishing date 2004-07-01T00:00:00Z
    Publisher JK Science
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    Full text online

    More links

    Kategorien

    Inter-library loan at ZB MED

    Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

  5. Article: Coexistence of phosphotyrosine-dependent and -independent interactions between Cbl and Bcr-Abl.

    Gaston, Isabelle / Johnson, Kara J / Oda, Tsukasa / Bhat, Arun / Reis, Margaret / Langdon, Wallace / Shen, Lei / Deininger, Michael W / Druker, Brian J

    Experimental hematology

    2004  Volume 32, Issue 1, Page(s) 113–121

    Abstract: Cbl is one of the major tyrosine-phosphorylated proteins in Bcr-Abl-expressing cells. A direct association between the SH2 domain of Bcr-Abl and tyrosine-phosphorylated Cbl has been demonstrated. The purpose of this study was to determine if and how ... ...

    Abstract Cbl is one of the major tyrosine-phosphorylated proteins in Bcr-Abl-expressing cells. A direct association between the SH2 domain of Bcr-Abl and tyrosine-phosphorylated Cbl has been demonstrated. The purpose of this study was to determine if and how unphosphorylated Cbl and Bcr-Abl may associate. Interactions between Cbl and Bcr-Abl were investigated in yeast two- and three-hybrid systems, gel overlay assays, and immunoprecipitates from mammalian cells expressing wild-type and the Y177F mutant of Bcr-Abl. No direct interaction between Bcr-Abl and unphosphorylated Cbl was observed. Bcr-Abl did, however, associate with Grb2, an adaptor protein that binds tyrosine 177 of Bcr-Abl. Additionally, Grb2 interacted with Cbl. In a yeast three-hybrid assay, Grb2 mediated an interaction between Cbl and Bcr-Abl that was dependent on a functional Grb2 binding site. This interaction was confirmed in vitro using purified proteins. In cells expressing Bcr-Abl with a mutation in the Grb2 binding site, binding of Cbl to Bcr-Abl was significantly reduced, but Cbl tyrosine phosphorylation was maintained. Imatinib treatment of these cells further reduced but did not abrogate Cbl binding, reflecting residual kinase activity. Multiple phosphotyrosine-dependent and -independent interactions stabilize the interaction between Cbl and Abl. Grb2 or another, yet unidentified, protein may mediate an initial interaction between Cbl and Bcr-Abl that is independent of Cbl tyrosine phosphorylation. Following this initial interaction, Cbl can then become tyrosine phosphorylated and interact with the SH2 domain of Bcr-Abl, further stabilizing the complex.
    MeSH term(s) Adaptor Proteins, Signal Transducing ; Animals ; Benzamides ; Fusion Proteins, bcr-abl/metabolism ; GRB2 Adaptor Protein ; Humans ; Imatinib Mesylate ; Mice ; Phosphorylation ; Phosphotyrosine/metabolism ; Piperazines/pharmacology ; Proteins/chemistry ; Proteins/physiology ; Proto-Oncogene Proteins/metabolism ; Proto-Oncogene Proteins c-cbl ; Pyrimidines/pharmacology ; Two-Hybrid System Techniques ; Tyrosine/metabolism ; Ubiquitin-Protein Ligases ; src Homology Domains
    Chemical Substances Adaptor Proteins, Signal Transducing ; Benzamides ; GRB2 Adaptor Protein ; GRB2 protein, human ; Grb2 protein, mouse ; Piperazines ; Proteins ; Proto-Oncogene Proteins ; Pyrimidines ; Phosphotyrosine (21820-51-9) ; Tyrosine (42HK56048U) ; Imatinib Mesylate (8A1O1M485B) ; Proto-Oncogene Proteins c-cbl (EC 2.3.2.27) ; Ubiquitin-Protein Ligases (EC 2.3.2.27) ; Fusion Proteins, bcr-abl (EC 2.7.10.2) ; CBL protein, human (EC 6.3.2.-) ; Cbl protein, mouse (EC 6.3.2.-)
    Language English
    Publishing date 2004-03-01
    Publishing country Netherlands
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Research Support, U.S. Gov't, P.H.S.
    ZDB-ID 185107-x
    ISSN 1873-2399 ; 0301-472X ; 0531-5573
    ISSN (online) 1873-2399
    ISSN 0301-472X ; 0531-5573
    DOI 10.1016/j.exphem.2003.09.018
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

    In stock of ZB MED Cologne/Königswinter

    Zs.A 922: Show issues Location:
    Je nach Verfügbarkeit (siehe Angabe bei Bestand)
    bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
    Jg. 1995 - 2021: Lesesall (1.OG)
    ab Jg. 2022: Lesesaal (EG)

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

To top